Daily Mail | 2 Nov 2021
- Recipients of the J&J COVID-19 vaccine are 3.5 times as likely to develop a rare, deadly, blood clotting condition than the general population, a new study finds
- Researchers found that 8.5 J&J recipients developed the clots for every 100,000 person years, compared to only 2.5 out of the general population
- Researchers found that women between aged 30 and 64 were most at risk of developing the clotting
- Authorization of the vaccine was paused for ten days during April due to concerns of the blood clotting developing in women
- Cerebral venous sinus thrombosis, or CVST, is a dangerous condition that can cause a person to suffer stroke, or even die
Johnson & Johnson‘s COVID-19 vaccine increases a person’s risk of developing rare blood clots, a new study suggests.
Researchers from the Mayo Clinic in Rochester, Minnesota, compared data from the general population before the pandemic to data gathered from reported vaccine side-effects suffered by Americans.
They found that a person who received the vaccine was 3.5 times as likely to develop brain blood clots as an average person before the pandemic.
